Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email email@example.com.
Check back regularly for news, coverage, and announcements about MAVA.
OpGen has raised $4 million in debt, warrants and securities funding from a group of investors led by In-Q-Tel, Citybizlist reported Tuesday.
Sindhu Madhusudan writes the genome analysis company has also obtained $11.6 million in debt funding from investors such as In-Q-Tel, Harris & Harris Group, Highland Capital Partners, CHL Medical Partners, jVEN Capital and Cross Creek Advisors.
Gaithersburg, Md.-based OpGen developer of MapSolver, a Whole Genome Mapping System-based software tool for genome sequence and map analysis work, according to the report.
The Wisconsin Alumni Research Foundation established OpGen in 2002 with Evan Jones as chairman and CEO, Citybizlist reports.
Madhusudan writes OpGen previously raised $57.6 million from three funding rounds.